125 related articles for article (PubMed ID: 7658164)
1. Immunological and functional properties of in vitro oxidized low density lipoprotein.
Harduin P; Tailleux A; Lestavel S; Clavey V; Fruchart JC; Fievet C
J Lipid Res; 1995 May; 36(5):919-30. PubMed ID: 7658164
[TBL] [Abstract][Full Text] [Related]
2. Resistance to LDL oxidative modifications of an N-terminal apolipoprotein B epitope.
Gandjini H; Gambert P; Athias A; Lallemant C
Atherosclerosis; 1991 Jul; 89(1):83-93. PubMed ID: 1722977
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification.
Sparrow CP; Parthasarathy S; Steinberg D
J Lipid Res; 1988 Jun; 29(6):745-53. PubMed ID: 3139813
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the macrophage low density lipoprotein receptor-binding domains in the uptake of oxidized low density lipoprotein.
Keidar S; Brook GJ; Rosenblat M; Fuhrman B; Dankner G; Aviram M
Arterioscler Thromb; 1992 Apr; 12(4):484-93. PubMed ID: 1373074
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactivity of apolipoprotein B-100 and binding to LDL-receptor of phospholipase A2-treated low density lipoproteins.
Korotaeva AA; Golovanova NK; Vlasik TN; Yanushevskaya EV; Tsibulsky VP; Yakushkin VV; Tvorogova MG; Morozkin AD; Prokazova NV
Biochemistry (Mosc); 1998 Dec; 63(12):1430-7. PubMed ID: 9916162
[TBL] [Abstract][Full Text] [Related]
6. Different apolipoprotein B breakdown patterns in models of oxidized low density lipoprotein.
Viita H; Närvänen O; Ylä-Herttuala S
Life Sci; 1999; 65(8):783-93. PubMed ID: 10466744
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactivity of apolipoprotein B-100 in oxidatively modified low density lipoprotein.
Valentinova NV; Gu ZW; Yang M; Yanushevskaya EV; Antonov IV; Guyton JR; Smith CV; Gotto AM; Yang CY
Biol Chem Hoppe Seyler; 1994 Oct; 375(10):651-8. PubMed ID: 7534086
[TBL] [Abstract][Full Text] [Related]
8. Lipolysis of LDL with phospholipase A2 alters the expression of selected apoB-100 epitopes and the interaction of LDL with cells.
Kleinman Y; Krul ES; Burnes M; Aronson W; Pfleger B; Schonfeld G
J Lipid Res; 1988 Jun; 29(6):729-43. PubMed ID: 2459282
[TBL] [Abstract][Full Text] [Related]
9. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation.
Steinbrecher UP; Lougheed M; Kwan WC; Dirks M
J Biol Chem; 1989 Sep; 264(26):15216-23. PubMed ID: 2768257
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity of apo B towards monoclonal antibodies that inhibit the LDL-receptor interaction: effects of LDL oxidation.
Negri S; Roma P; Fogliatto R; Uboldi P; Marcovina S; Catapano AL
Atherosclerosis; 1993 Jun; 101(1):37-41. PubMed ID: 7692863
[TBL] [Abstract][Full Text] [Related]
11. An immunochemical marker of low density lipoprotein oxidation.
Zawadzki Z; Milne RW; Marcel YL
J Lipid Res; 1989 Jun; 30(6):885-91. PubMed ID: 2477481
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of low density lipoprotein particles decreases their ability to bind to human aortic proteoglycans. Dependence on oxidative modification of the lysine residues.
Oörni K; Pentikäinen MO; Annila A; Kovanen PT
J Biol Chem; 1997 Aug; 272(34):21303-11. PubMed ID: 9261142
[TBL] [Abstract][Full Text] [Related]
13. Melatonin inhibits oxidative modification of human low-density lipoprotein.
Kelly MR; Loo G
J Pineal Res; 1997 May; 22(4):203-9. PubMed ID: 9247205
[TBL] [Abstract][Full Text] [Related]
14. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.
Hanasaki K; Yamada K; Yamamoto S; Ishimoto Y; Saiga A; Ono T; Ikeda M; Notoya M; Kamitani S; Arita H
J Biol Chem; 2002 Aug; 277(32):29116-24. PubMed ID: 12021277
[TBL] [Abstract][Full Text] [Related]
15. Non-oxidative modification of native low-density lipoprotein by oxidized low-density lipoprotein.
Yang M; Leake DS; Rice-Evans CA
Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):377-80. PubMed ID: 8687375
[TBL] [Abstract][Full Text] [Related]
16. Use of monoclonal antibodies in studies of lipoprotein structure and function.
Schonfeld G; Tikkanen MJ; Hahm KS
Adv Exp Med Biol; 1985; 183():135-57. PubMed ID: 2412411
[TBL] [Abstract][Full Text] [Related]
17. Oxidative events cause degradation of apoB-100 but not of apo[a] and facilitate enzymatic cleavage of both proteins.
Edelstein C; Nakajima K; Pfaffinger D; Scanu AM
J Lipid Res; 2001 Oct; 42(10):1664-70. PubMed ID: 11590223
[TBL] [Abstract][Full Text] [Related]
18. Expression of apolipoprotein B epitopes in lipoproteins. Relationship to conformation and function.
Marcel YL; Hogue M; Weech PK; Davignon J; Milne RW
Arteriosclerosis; 1988; 8(6):832-44. PubMed ID: 2461695
[TBL] [Abstract][Full Text] [Related]
19. Reduced uptake of cholesterol esterase-modified low density lipoprotein by macrophages.
Aviram M; Keidar S; Rosenblat M; Brook GJ
J Biol Chem; 1991 Jun; 266(18):11567-74. PubMed ID: 1711036
[TBL] [Abstract][Full Text] [Related]
20. Time-course studies by neutron solution scattering and biochemical assays of the aggregation of human low-density lipoprotein during Cu(2+)-induced oxidation.
Meyer DF; Mayans MO; Groot PH; Suckling KE; Bruckdorfer KR; Perkins SJ
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):417-26. PubMed ID: 7654177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
